The concept of triple wavefront fusion during biventricular pacing: Using the EGM to produce the best acute hemodynamic improvement in CRT.
Autor: | Ter Horst IAH; Department of Cardiology, University Medical Center Utrecht, Utrecht, The Netherlands., Bogaard MD; Department of Cardiology, University Medical Center Utrecht, Utrecht, The Netherlands., Tuinenburg AE; Department of Cardiology, University Medical Center Utrecht, Utrecht, The Netherlands., Mast TP; Department of Cardiology, University Medical Center Utrecht, Utrecht, The Netherlands., de Boer TP; Department of Medical Physiology, University Medical Center Utrecht, Utrecht, The Netherlands., Doevendans PAFM; Department of Cardiology, University Medical Center Utrecht, Utrecht, The Netherlands., Meine M; Department of Cardiology, University Medical Center Utrecht, Utrecht, The Netherlands. |
---|---|
Jazyk: | angličtina |
Zdroj: | Pacing and clinical electrophysiology : PACE [Pacing Clin Electrophysiol] 2017 Jul; Vol. 40 (7), pp. 873-882. Date of Electronic Publication: 2017 Jun 16. |
DOI: | 10.1111/pace.13118 |
Abstrakt: | Background: Previous reports suggest that biventricular pacing (BiVp) fused with intrinsic conduction (BiVp-fusion, triple wavefront fusion) is associated with improved resynchronization compared to pure-BiVp in cardiac resynchronization therapy (CRT). This study aimed to assess the association between acute hemodynamic benefit of CRT and signs of BiVp-fusion by using a novel electrogram (EGM)-based method. Methods: In 17 patients undergoing CRT implantation, 28 combinations of atrioventricular (AV) and interventricular (VV) delays were applied while invasively measuring acute hemodynamic response based on maximum rate of left ventricular (LV) pressure rise (LV dP/dt Results: Mean optimal RVp timing was at 98 ± 17% of intrinsic right atrial (RA)-RV Conclusion: Optimal hemodynamic BiVp facilitates triple wavefront fusion, by pacing the RV around the onset of intrinsic farfield signal on RV EGM, while preactivating the LV. Aiming at BiVp-fusion could be a target for noninvasive EGM-based CRT device setting optimization. (© 2017 Wiley Periodicals, Inc.) |
Databáze: | MEDLINE |
Externí odkaz: | |
Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |